Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.
Cellcolabs has raised $12.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Cellcolabs's investors include Norrsken VC, Titan Capital, Unruly Capital, Jonas Nordlander, Filip Engelbert.
Cellcolabs is headquartered in Solna, Sweden.
Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.
Cellcolabs is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellcolabs — Funding & Investors." VCBacked, October 27, 2025, https://www.vcbacked.co/company/cellcolabs. Accessed September 25, 2026.
VCBacked. (2025). Cellcolabs — Funding & Investors. Retrieved September 25, 2026, from https://www.vcbacked.co/company/cellcolabs
{{cite web |title=Cellcolabs — Funding & Investors |url=https://www.vcbacked.co/company/cellcolabs |website=VCBacked |access-date=September 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated